Among the evaluated markers, TNF-α, sFas and sFas-L were significantly increased in the SLE patients compared to the healthy controls (p = 0.009, p < 0.001 and p = 0.045, respectively), indicating elevated systemic inflammation. Here, FASLG is linked to systemic lupus erythematosus.